Technologies Available for Licensing
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) N-TERMINAL DELETED GP120 IMMUNOGENS
The present invention relates, in general, to human immunodeficiency virus (HIV), and in particular to a vaccine for HIV-1 and to methods of making and using same.
More Detail:Visit USPTO.GOV
Inventor(s):HAYNES, ET AL